{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:20:15Z","timestamp":1778300415995,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.jaad.2004.07.034","type":"journal-article","created":{"date-parts":[[2005,4,28]],"date-time":"2005-04-28T09:14:07Z","timestamp":1114679647000},"page":"S81-S85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"S","title":["Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl"],"prefix":"10.1016","volume":"52","author":[{"given":"Andrew J.","family":"Racette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Henry H.","family":"Roenigk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Mendelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anngela","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.07.034_bib1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1651-2227.2003.tb00636.x","article-title":"Bone and joint infection after traumatic implantation of Scedosporium prolificans treated with voriconazole and surgery","volume":"92","author":"Studahl","year":"2003","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaad.2004.07.034_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s10096-003-0960-0","article-title":"Voriconazole in the treatment of invasive mold infections in transplant recipients","volume":"22","author":"D\u00e1vila","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jaad.2004.07.034_bib3","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JCM.41.8.3623-3626.2003","article-title":"Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi","volume":"41","author":"Diekema","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaad.2004.07.034_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00001432-200212000-00004","article-title":"Laboratory evaluation of new antifungal agents against rare and refractory mycoses","volume":"15","author":"Fort\u00fan","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jaad.2004.07.034_bib5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0149-2918(03)80126-1","article-title":"Voriconazole","volume":"25","author":"Jeu","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2004.07.034_bib6","unstructured":"Food and Drug Administration. Antiviral drugs advisory committee briefing document for voriconazole. Available from: URL:http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/briefing\/3792 b2_01_pfizer.pdf. Accessed October 24, 2003."},{"key":"10.1016\/j.jaad.2004.07.034_bib7","unstructured":"Baildon R. Pfizer global research and development. Available from: URL:http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/slides\/3792s2_01_1-Pfizer-main.ppt. Accessed October 13, 2003."},{"key":"10.1016\/j.jaad.2004.07.034_bib8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1365-2230.2001.00909.x","article-title":"Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole","volume":"26","author":"Denning","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2004.07.034_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1185\/030079903125001884","article-title":"Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole","volume":"19","author":"Ullmann","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaad.2004.07.034_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/13543784.11.3.409","article-title":"Review of the safety and efficacy of voriconazole","volume":"11","author":"Hoffman","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2004.07.034_bib11","series-title":"VFEND (voriconazole)","year":"2002"},{"key":"10.1016\/j.jaad.2004.07.034_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2004.07.034_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.07.034_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.07.034_bib15","first-page":"648","article-title":"Photosensitivity related to the novel triazole antifungal agent voriconazole","volume":"26","author":"Denning","year":"2001","journal-title":"J Exp Dermatol"},{"key":"10.1016\/j.jaad.2004.07.034_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0733-8635(03)00024-X","article-title":"New antifungal agents","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2004.07.034_bib17","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1086\/375235","article-title":"Successful treatment of coccidioidal meningitis with voriconazole","volume":"36","author":"Cortez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2004.07.034_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/bj2680371","article-title":"Retinol and retinal metabolism: relationship to the state of differentiation of cultured human keratinocytes","volume":"268","author":"Siegenthaler","year":"1990","journal-title":"Biochem J"},{"key":"10.1016\/j.jaad.2004.07.034_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-3565(25)13356-9","article-title":"Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats","volume":"252","author":"Van Wauwe","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2004.07.034_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2133.1995.tb02672.x","article-title":"Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liarozole","volume":"133","author":"Dockx","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.07.034_bib21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0022-3565(25)11103-8","article-title":"Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo","volume":"261","author":"Van Wauwe","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2004.07.034_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/1389557023406223","article-title":"Cytochrome P450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapy","volume":"2","author":"Njar","year":"2002","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.jaad.2004.07.034_bib23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-3565(25)22669-6","article-title":"Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid","volume":"245","author":"Van Wauwe","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2004.07.034_bib24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1172\/JCI115990","article-title":"Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydro-xyretinoic acid after topical application and retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro","volume":"90","author":"Duell","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2004.07.034_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00003495-198734040-00003","article-title":"The retinoids: a review of their clinical pharmacology and therapeutic use","volume":"34","author":"Orlanos","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2004.07.034_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/1523-1747.ep12470632","article-title":"Cellular immunologic and biochemical characterization of topical retinoic acid-treated human skin","volume":"96","author":"Fisher","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2004.07.034_bib27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/dmd.31.5.540","article-title":"Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole","volume":"31","author":"Hyland","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaad.2004.07.034_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0891-5520(02)00068-5","article-title":"Clinical pharmacology of antifungal compounds","volume":"17","author":"Groll","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jaad.2004.07.034_bib29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1124\/dmd.31.6.731","article-title":"The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human","volume":"31","author":"Roffey","year":"2003","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204019450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204019450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:36:59Z","timestamp":1759268219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204019450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0190962204019450"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.07.034","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2004.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}